On December 14, 2017, Orphazyme A/S, University of Kansas Medical Center, and UCL announced that Orphazyme formally assumes the...
Investigators are seeking people with dermatomyositis to participate in a phase 2 clinical trial of the experimental drug IMO-8400....
Choose your language
- Explore Myositis
- Financial Assistance Program
- #ItsMyTurn: Becoming a Plasma Donor Hero
- Myositis Clinical Trials
- Myositis Empower Walk
- Myositis Webinars
- The Grieving Project
- Upcoming Events
January 29 @ 5:00 pm - 6:30 pm EST
January 30 @ 3:00 pm - 4:30 pm EST
February 3 @ 7:00 pm - 8:30 pm EST